Tomoregulin-1 prevents cardiac hypertrophy after pressure overload in mice by inhibiting TAK1-JNK pathways
Cardiac hypertrophy is associated with many forms of heart disease, and identifying important modifier genes involved in the pathogenesis of cardiac hypertrophy could lead to the development of new therapeutic strategies. Tomoregulin-1 is a growth factor that is primarily involved in embryonic devel...
Saved in:
Main Authors: | Dan Bao (Author), Dan Lu (Author), Ning Liu (Author), Wei Dong (Author), Ying-Dong Lu (Author), Chuan Qin (Author), Lian-Feng Zhang (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2015-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ganoderma lucidum polysaccharides attenuates pressure-overload-induced pathological cardiac hypertrophy
by: Changlin Zhen, et al.
Published: (2023) -
Maslinic acid protects against pressure overload-induced cardiac hypertrophy in mice
by: Yan-Ling Liu, et al.
Published: (2018) -
5-HT3 receptor antagonists protect against pressure overload-induced cardiac hypertrophy in murine
by: Rong Huo, et al.
Published: (2012) -
Empagliflozin improves pressure-overload-induced cardiac hypertrophy by inhibiting the canonical Wnt/β-catenin signaling pathway
by: Xun Yuan, et al.
Published: (2024) -
The Anti-Inflammatory Mediator 17(R)-Resolvin D1 Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
by: Wang M, et al.
Published: (2023)